Recombinant invasive Lactococcus lactis carrying a DNA vaccine coding the Ag85A antigen increases INF-γ, IL-6, and TNF-α cytokines after intranasal immunization

Frontiers in Microbiology

Volumn 8, Issue JUL, 2017, Pages

  Mancha Agresti, Pamela ^a   de Castro, Camila Prosperi ^a   dos Santos, Janete S C ^b   Araujo, Maíra A ^b   Pereira, Vanessa B ^a   LeBlanc, Jean G ^c   Leclercq, Sophie Y ^b   Azevedo, Vasco ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FUNDAÇÃO EZEQUIEL DIAS   (Brazil)

^c Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Ag85A; Lactic acid bacteria; Lactococcus lactis; Mucosal vaccine; Tuberculosis

Indexed keywords

AG 85A; CYTOKINE; DNA VACCINE; GAMMA INTERFERON; GENOMIC DNA; IMMUNOGLOBULIN; RECOMBINANT VACCINE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; CELLULAR IMMUNITY; CONFOCAL MICROSCOPY; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; EUKARYOTIC CELL; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSFECTION; IMMUNIZATION; LACTOCOCCUS LACTIS; MOUSE; NONHUMAN; OPEN READING FRAME; PLASMID; POLYMERASE CHAIN REACTION; SPLEEN CELL; TUBERCULOSIS;

EID: 85024124300     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2017.01263     Document Type: Article

References (71)

1. Agger, E. M. (2016). Novel adjuvant formulations for delivery of anti-tuberculosis vaccine candidates. Adv. Drug Deliv. Rev. 102, 73-82. doi: 10.1016/j.addr.2015.11.012
2. Almeida, J. F., Mariat, D., Azevedo, V., Miyoshi, A., de Moreno LeBlanc, A., Del Carmen, S., et al. (2014). Correlation between fibronectin binding protein A expression level at the surface of recombinant Lactococcus lactis and plasmid transfer in vitro and in vivo. BMC Microbiol. 14:248. doi: 10.1186/s12866-014-0248-9
3. Andersen, P., and Urdahl, K. B. (2015). TB vaccines; promoting rapid and durable protection in the lung. Curr. Opin. Immunol. 35, 55-62. doi: 10.1016/j.coi.2015.06.001
4. Anuradha, B., Rakh, S. S., Ishaq, M., Murthy, K. J. R., and Valluri, V. L. (2008). Interferon-gamma Low producer genotype +874 overrepresented in Bacillus Calmette-Guerin nonresponding children. Pediatr. Infect. Dis. J. 27, 325-329. doi: 10.1097/INF.0b013e31816099e6
5. Anuradha, B., Santosh, C. M., Hari Sai Priya, V., Suman Latha, G., Murthy, K. J. R., and Vijaya Lakshmi, V. (2007). Age-related waning of in vitro Interferon-gamma levels against r32kDaBCG in BCG vaccinated children. J. Immune Based Ther. Vaccines 5:8. doi: 10.1186/1476-8518-5-8
6. Armitige, L. Y., Jagannath, C., Wanger, A. R., and Norris, S. J. (2000). Disruption of the genes encoding antigen 85A and antigen 85B of Mycobacterium tuberculosis H37Rv: effect on growth in culture and in macrophages. Infect. Immun. 68, 767-778. doi: 10.1128/IAI.68.2.767-778.2000
7. Bermúdez-Humarán, L. G., Cortes-Perez, N. G., Lefèvre, F., Guimarães, V., Rabot, S., Alcocer-Gonzalez, J. M., et al. (2005). A novel mucosal vaccine based on live Lactococci expressing E7 antigen and IL-12 induces systemic and mucosal immune responses and protects mice against human papillomavirus type 16-induced tumors. J. Immunol. 175, 7297-7302. doi: 10.4049/jimmunol.175.11.7297
8. Bermúdez-Humarán, L. G., Langella, P., Cortes-Perez, N. G., Gruss, A., Tamez-Guerra, R. S., Oliveira, S. C., et al. (2003). Intranasal immunization with recombinant Lactococcus lactis secreting murine interleukin-12 enhances antigen-specific Th1 cytokine production. Infect. Immun. 71, 1887-1896. doi: 10.1128/IAI.71.4.1887-1896.2003
9. Borrero, R., García, M., de Los, A., Canet, L., Zayas, C., Reyes, F., et al. (2013). Evaluation of the humoral immune response and cross reactivity against Mycobacterium tuberculosis of mice immunized with liposomes containing glycolipids of Mycobacterium smegmatis. BMC Immunol. 14(Suppl. 1):S13. doi: 10.1186/1471-2172-14-S1-S13
10. Brian, E., Gounant, V., Fulgencio, J.-P., Milleron, B., and Bazelly, B. (2007). Tracheal replacement using the abdominal aorta. Comments on a case report. Rev. Pneumol. Clin. 63, 224-229. doi: 10.1016/S0761-8417(07)90127-3
11. Cerutti, A. (2008). The regulation of IgA class switching. Nat. Rev. Immunol. 8, 421-434. doi: 10.1038/nri2322
12. Chatel, J.-M., Pothelune, L., Ah-Leung, S., Corthier, G., Wal, J.-M., and Langella, P. (2008). In vivo transfer of plasmid from food-grade transiting lactococci to murine epithelial cells. Gene Ther. 15, 1184-1190. doi: 10.1038/gt.2008.59
13. Cooper, A. M. (2009). Cell-mediated immune responses in tuberculosis. Annu. Rev. Immunol. 27, 393-422. doi: 10.1146/annurev.immunol.021908.132703
14. Cortes-Perez, N. G., Ah-Leung, S., Bermúdez-Humarán, L. G., Corthier, G., Wal, J. M., Langella, P., et al. (2007). Intranasal coadministration of live lactococci producing interleukin-12 and a major cow's milk allergen inhibits allergic reaction in mice. Clin. Vaccine Immunol. 14, 226-233. doi: 10.1128/CVI.00299-06
15. da Costa, C., Walker, B., and Bonavia, A. (2015). Tuberculosis vaccines-state of the art, and novel approaches to vaccine development. Int. J. Infect. Dis. 32, 5-12. doi: 10.1016/j.ijid.2014.11.026
16. de Azevedo, M., Meijerink, M., Taverne, N., Pereira, V. B., LeBlanc, J. G., Azevedo, V., et al. (2015). Recombinant invasive Lactococcus lactis can transfer DNA vaccines either directly to dendritic cells or across an epithelial cell monolayer. Vaccine 33, 4807-4812. doi: 10.1016/j.vaccine.2015.07.077
17. Detmer, A., and Glenting, J. (2006). Live bacterial vaccines-a review and identification of potential hazards. Microb. Cell Fact. 5:23. doi: 10.1186/1475-2859-5-23
18. Dietrich, J., Vingsbo Lundberg, C., and Andersen, P. (2006). TB vaccine strategies-What is needed to solve a complex problem? Tuberculosis 86, 163-168. doi: 10.1016/j.tube.2006.01.009
19. Donnelly, J. J., Ulmer, J. B., and Liu, M. A. (1996). Minireview: DNA vaccines. Life Sci. 60, 163-172. doi: 10.1016/S0024-3205(96)00502-4
20. Dou, J., Tang, Q., Yu, F., Yang, H., Zhao, F., Xu, W., et al. (2010). Investigation of immunogenic effect of the BCG priming and Ag85A-GM-CSF boosting in Balb/c mice model. Immunobiology 215, 133-142. doi: 10.1016/j.imbio.2009.04.002
21. Drowart, A., Bruyn, J., Huygen, K., Damiani, G., Godfrey, H. P., Stelandre, M., et al. (1992). Isoelectrophoretic characterization of protein antigens present in mycobacterial culture filtrates and recognized by monoclonal antibodies directed against the Mycobacterium bovis BCG antigen 85 complex. Scand. J. Immunol. 36, 697-702. doi: 10.1111/j.1365-3083.1992.tb03130.x
22. D'Souza, S., Rosseels, V., Romano, M., Tanghe, A., Denis, O., Jurion, F., et al. (2003). Mapping of murine Th1 helper T-cell epitopes of mycolyl transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis. Infect. Immun. 71, 483-493. doi: 10.1128/IAI.71.1.483-493.2003
23. Dunham, S. P. (2002). The application of nucleic acid vaccines in veterinary medicine. Res. Vet. Sci. 73, 9-16. doi: 10.1016/S0034-5288(02)00032-2
24. Fletcher, H. A., Snowden, M. A., Landry, B., Rida, W., Satti, I., Harris, S. A., et al. (2016). T-cell activation is an immune correlate of risk in BCG vaccinated infants. Nat. Commun. 7:11290. doi: 10.1038/ncomms11290
25. Flynn, J. L., Chan, J., Of, M., Flynn, U. J. L., Chan, J., Flynn, J. L., et al. (2001). Immunology of tuberculosis. Annu. Rev. Immunol. 19, 93-129. doi: 10.1146/annurev.immunol.19.1.93
26. Green, M. R., and Sambrook, J. (2012). Molecular Cloning: A Laboratory Manual, 4th Edn. New York, NY: Cold Spring Harbor
27. Grillot-Courvalin, C., Goussard, S., and Courvalin, P. (1999). Bacteria as gene delivery vectors for mammalian cells. Curr. Opin. Biotechnol. 10, 477-481. doi: 10.1016/S0958-1669(99)00013-0
28. Guimarães, V., Innocentin, S., Chatel, J.-M., Lefèvre, F., Langella, P., Azevedo, V., et al. (2009). A new plasmid vector for DNA delivery using lactococci. Genet. Vaccines Ther. 7:4. doi: 10.1186/1479-0556-7-4
29. Guimaraes, V. D., Innocentin, S., Lefevre, F., Azevedo, V., Wal, J.-M., Langella, P., et al. (2006). Use of native lactococci as vehicles for delivery of DNA into mammalian epithelial cells. Appl. Environ. Microbiol. 72, 7091-7097. doi: 10.1128/AEM.01325-06
30. Holmgren, J., and Czerkinsky, C. (2005). Mucosal immunity and vaccines. Nat. Med. 11(Suppl. 4), S45-S53. doi: 10.1038/nm1213
31. Hugentobler, F., Yam, K. K., Gillard, J., Mahbuba, R., Olivier, M., and Cousineau, B. (2012). Immunization against Leishmania major infection using LACK-and IL-12-expressing Lactococcus lactis induces delay in footpad swelling. PLoS ONE 7:e30945. doi: 10.1371/journal.pone.0030945
32. Huygen, K., Content, J., Denis, O., Montgomery, D. L., Yawman, A. M., Deck, R. R., et al. (1996). Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat. Med. 2, 893-898. doi: 10.1038/nm0896-893
33. Huygen, K., Lozes, E., Gilles, B., Drowart, A., Palfliet, K., Jurion, F., et al. (1994). Mapping of TH1 helper T-cell epitopes on major secreted mycobacterial antigen 85A in mice infected with live Mycobacterium bovis BCG. Infect. Immun. 62, 363-370
34. Innocentin, S., Guimaraes, V., Miyoshi, A., Azevedo, V., Langella, P., Chatel, J.-M., et al. (2009). Lactococcus lactis expressing either Staphylococcus aureus fibronectin-binding protein A or Listeria monocytogenes internalin A can efficiently internalize and deliver DNA in human epithelial cells. Appl. Environ. Microbiol. 75, 4870-4878. doi: 10.1128/AEM.00825-09
35. Jain, R., Dey, B., Dhar, N., Rao, V., Singh, R., Gupta, U. D., et al. (2008). Enhanced and enduring protection against tuberculosis by recombinant BCG-Ag85C and its association with modulation of cytokine profile in lung. PLoS ONE 3:e3869. doi: 10.1371/journal.pone.0003869
36. Kaufmann, S. H. E. (2004). New issues in tuberculosis. Ann. Rheum. Dis. 63(Suppl. 2), ii50-ii56. doi: 10.1136/ard.2004.028258
37. Kaufmann, S. H. E. (2010). Future vaccination strategies against tuberculosis: thinking outside the Box. Immunity 33, 567-577. doi: 10.1016/j.immuni.2010.09.015
38. Kiyono, H., Bienenstock, J., McGhee, J. R., and Ernst, P. B. (1991). The mucosal immune system: features of inductive and effector sites to consider in mucosal immunization and vaccine development. Reg. Immunol. 4, 54-62
39. Langella, P. Y., Le Loir, S. D., and Ehrlich, A. G. (1993). Efficient plasmid mobilization by pIP501 in Lactococcus lactis subsp. lactis. J. Bacteriol. 175, 5806-5813. doi: 10.1128/jb.175.18.5806-5813.1993
40. Lighvani, A. A., Frucht, D. M., Jankovic, D., Yamane, H., Aliberti, J., Hissong, B. D., et al. (2001). T-bet is rapidly induced by interferon-gamma in lymphoid and myeloid cells. Proc. Natl. Acad. Sci. U.S.A. 98, 15137-15142. doi: 10.1073/pnas.261570598
41. Lycke, N. (2012). Recent progress in mucosal vaccine development: potential and limitations. Nat. Rev. Immunol. 12, 592-605. doi: 10.1038/nri3251
42. Mancha-Agresti, P., Drumond, M. M., Rosa do Carmo, F. L., Santos, M. M., Coelho dos Santos, J. S., et al. (2016). A new broad range plasmid for DNA delivery in eukaryotic cells using lactic acid bacteria: in vitro and in vivo assays. Mol. Ther. Methods Clin. Dev. 4, 83-91. doi: 10.1016/j.omtm.2016.12.005
43. Mancha-Agresti, P., Sousa, C. S., do Carmo, F. L. R., Oliveira, A. F. Jr., Azevedo, V., and de Azevedo, M. S. P. (2015). Future clinical applications of the potential use of lactic acid bacteria as vehicles to deliver DNA vaccines. Austin J. Vaccines Immunother. 2, 1006
44. Medina, M., Villena, J., Vintini, E., Hebert, E. M., Raya, R., and Alvarez, S. (2008). Nasal immunization with Lactococcus lactis expressing the pneumococcal protective protein A induces protective immunity in mice. Infect. Immun. 76, 2696-2705. doi: 10.1128/IAI.00119-08
45. Meeusen, E. N. (2011). Exploiting mucosal surfaces for the development of mucosal vaccines. Vaccine 29, 8506-8511. doi: 10.1016/j.vaccine.2011.09.010
46. Mestecky, J. (1987). The common mucosal immune system and current strategies for induction of immune responses in external secretions. J. Clin. Immunol. 7, 265-276. doi: 10.1007/BF00915547
47. Neutra, M. R., and Kozlowski, P. A. (2006). Mucosal vaccines: the promise and the challenge. Nat. Rev. Immunol. 6, 148-158. doi: 10.1038/nri1777
48. Nizard, M., Diniz, M. O., Roussel, H., Tran, T., Ferreira, L. C., Badoual, C., et al. (2014). Mucosal vaccines: novel strategies and applications for the control of pathogens and tumors at mucosal sites. Hum. Vaccines Immunother. 10, 2175-2187. doi: 10.4161/hv.29269
49. Olivares, N., Marquina, B., Mata-Espinoza, D., Zatarain-Barron, Z. L., Pinzón, C. E., Estrada, I., et al. (2013). The protective effect of immunoglobulin in murine tuberculosis is dependent on IgG glycosylation. Pathog. Dis. 69, 176-183. doi: 10.1111/2049-632X.12069
50. Ottenhoff, T. H. M. (2012). New pathways of protective and pathological host defense to mycobacteria. Trends Microbiol. 20, 419-428. doi: 10.1016/j.tim.2012.06.002
51. Ottenhoff, T. H. M., and Kaufmann, S. H. E. (2012). Vaccines against tuberculosis: where are we and where do we need to go? PLoS Pathog. 8:e1002607. doi: 10.1371/journal.ppat.1002607
52. Parida, S. K., Huygen, K., Ryffel, B., and Chakraborty, T. (2005). Novel bacterial delivery system with attenuated Salmonella typhimurium carrying plasmid encoding Mtb antigen 85A for mucosal immunization: establishment of proof of principle in TB mouse model. Ann. N. Y. Acad. Sci. 1056, 366-378. doi: 10.1196/annals.1352.030
53. Pereira, V. B., da Cunha, V. P., Preisser, T. M., Souza, B. M., Turk, M. Z., De Castro, C. P., et al. (2017). Lactococcus lactis carrying a DNA vaccine coding for the ESAT-6 antigen increases IL-17 cytokine secretion and boosts the BCG vaccine immune response. J. Appl. Microbiol. 122, 1657-1662. doi: 10.1111/jam.13449
54. Pereira, V. B., Saraiva, T. D. L., Souza, B. M., Zurita-Turk, M., Azevedo, M. S. P., De Castro, C. P., et al. (2015). Development of a new DNA vaccine based on mycobacterial ESAT-6 antigen delivered by recombinant invasive Lactococcus lactis FnBPA+. Appl. Microbiol. Biotechnol. 99, 1817-1826. doi: 10.1007/s00253-014-6285-3
55. Pfeiler, E. A., and Klaenhammer, T. R. (2007). The genomics of lactic acid bacteria. Trends Microbiol. 15, 546-553. doi: 10.1016/j.tim.2007.09.010
56. Priya, V. H. S., Anuradha, B., Gaddam, S. L., Hasnain, S. E., Murthy, K. J. R., and Valluri, V. L. (2009). In vitro levels of interleukin 10 (IL-10) and IL-12 in response to a recombinant 32-kilodalton antigen of Mycobacterium bovis BCG after treatment for tuberculosis. Clin. Vaccine Immunol. 16, 111-115. doi: 10.1128/CVI.00243-08
57. Que, Y. A., François, P., Haefliger, J. A., Entenza, J. M., Vaudaux, P., and Moreillon, P. (2001). Reassessing the role of Staphylococcus aureus clumping factor and fibronectin-binding protein by expression in Lactococcus lactis. Infect. Immun. 69, 6296-6302. doi: 10.1128/IAI.69.10.6296-6302.2001
58. Robert, S., and Steidler, L. (2014). Recombinant Lactococcus lactis can make the difference in antigen-specific immune tolerance induction, the type 1 diabetes case. Microb. Cell Fact. 13(Suppl. 1):S11. doi: 10.1186/1475-2859-13-S1-S11
59. Romano, M., D'Souza, S., Adnet, P. Y., Laali, R., Jurion, F., Palfliet, K., et al. (2006). Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv. Vaccine 24, 3353-3364. doi: 10.1016/j.vaccine.2005.12.066
60. Rosada, R. S., Torre, L., Frantz, F. G., Trombone, A. P., Zárate-Bladés, C. R., Fonseca, D. M., et al. (2008). Protection against tuberculosis by a single intranasal administration of DNA-hsp65 vaccine complexed with cationic liposomes. BMC Immunol. 9:38. doi: 10.1186/1471-2172-9-38
61. Rosales-Mendoza, S., Angulo, C., and Meza, B. (2016). Food-grade organisms as vaccine biofactories and oral delivery vehicles. Trends Biotechnol. 34, 124-136. doi: 10.1016/j.tibtech.2015.11.007
62. Saito, S., and Nakano, M. (1996). Nitric oxide production by peritoneal macrophages of Mycobacterium bovis BCG-infected or non-infected mice: regulatory role of T lymphocytes and cytokines. J. Leukoc. Biol. 59, 908-915
63. Sánchez-Rodríguez, C., Estrada-Chávez, C., García-Vigil, J., Laredo-Sánchez, F., Halabe-Cherem, J., Pereira-Suárez, A., et al. (2002). An IgG antibody response to the antigen 85 complex is associated with good outcome in Mexican Totonaca Indians with pulmonary tuberculosis. Int. J. Tuberc. Lung Dis. 6, 706-712
64. Schoen, C., Stritzker, J., Goebel, W., and Pilgrim, S. (2004). Bacteria as DNA vaccine carriers for genetic immunization. Int. J. Med. Microbiol. 294, 319-335. doi: 10.1016/j.ijmm.2004.03.001
65. Takizawa, H. (2005). Bronchial epithelial cells in allergic reactions. Curr. Drug Targets Inflamm. Allergy 4, 305-311. doi: 10.2174/1568010054022123
66. Todoroff, J., Lemaire, M. M., Fillee, C., Jurion, F., Renauld, J.-C., Huygen, K., et al. (2013). Mucosal and systemic immune responses to Mycobacterium tuberculosis antigen 85A following its co-delivery with CpG. MPLA or LTB to the lungs in mice. PLoS ONE 8:e63344. doi: 10.1371/journal.pone.0063344
67. Vijayalakshmi, V., Devi, P. S., Murthy, K. J., Rao, D. V., and Jain, S. N. (1993). Cell mediated immune responses in BCG vaccinated children. Indian Pediatr. 30, 899-903
68. Wells, J. M., and Mercenier, A. (2008). Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria. Nat. Rev. Microbiol. 6, 349-362. doi: 10.1038/nrmicro1840
69. WHO (2016). Global Tuberculosis Report. Geneva: World Health Organization
70. Williams, A., Reljic, R., Naylor, I., Clark, S. O., Falero-Diaz, G., Singh, M., et al. (2004). Passive protection with immunoglobulin A antibodies against tuberculous early infection of the lungs. Immunology 111, 328-333. doi: 10.1111/j.1365-2567.2004.01809.x
71. Yuan, W., Dong, N., Zhang, L., Liu, J., Lin, S., Xiang, Z., et al. (2012). Immunogenicity and protective efficacy of a tuberculosis DNA vaccine expressing a fusion protein of Ag85B-Esat6-HspX in mice. Vaccine 30, 2490-2497. doi: 10.1016/j.vaccine.2011.06.029